{
    "Participant": "huBA30D4", 
    "Report URL": "http://evidence.personalgenomes.org/genomes?display_genome_id=6a5afdba4ef423ae550f5b355ae609ccc350ec63&access_token=e64b660ee6460c745a43a527be843031", 
    "Variants": [
        {
            "Allele Frequency": "0.0018", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "89866691", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "POLG", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "16634032"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "5", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported in a single case of two sisters with early-onset parkinsonianism. Hypothesized to cause their disease in a recessive manner, but no statistical significance.", 
            "URL": "http://evidence.pgp-hms.org/POLG-G737R", 
            "Variant Name": "POLG-G737R", 
            "Variant Page": "http://evidence.pgp-hms.org/POLG-G737R"
        }, 
        {
            "Allele Frequency": "0.019", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "219755011", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Mouth, liver, and digestive", 
                "Skin"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "WNT10A", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "19559398", 
                "20979233"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "1", 
                "Functional": null, 
                "Penetrance": "5", 
                "Severity": "3", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Causes ectodermal dysplasia in a recessive manner (malformations of teeth and nails, abnormal/loss of sweating). Although reports have high statistical significance, allele frequency for this variant is high relative to the incidence of the disease. This suggests it may be milder than other pathogenic variants and cause disease with less than 100% penetrance and/or that the disease is more common than reported. Bohring et al. report heterozygotes for pathogenic variants in this gene often have milder skin, tooth, and nail abnormalities, with males having a higher rate of tooth abnormalities.", 
            "URL": "http://evidence.pgp-hms.org/WNT10A-F228I", 
            "Variant Name": "WNT10A-F228I", 
            "Variant Page": "http://evidence.pgp-hms.org/WNT10A-F228I"
        }, 
        {
            "Allele Frequency": "0.089", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "12393125", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PPARG", 
            "Impact": "Not Reviewed", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "16783862", 
                "17213274", 
                "17463248"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "3", 
                "Familial": "1", 
                "Functional": "1", 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": null, 
            "URL": "http://evidence.pgp-hms.org/PPARG-P12A", 
            "Variant Name": "PPARG-P12A", 
            "Variant Page": "http://evidence.pgp-hms.org/PPARG-P12A", 
            "dbSNP IDs": [
                "rs1801282"
            ]
        }, 
        {
            "Allele Frequency": "0.061", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "13152400", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "OPTN", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "11834836", 
                "14627677", 
                "19145250"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant was initially reported to be a risk factor for glaucoma, but subsequent reports have failed to find a statistically significant association. It may have a modifier effect, with carriers of the variant having lower intraocular pressure on average -- pressures that might be considered normal in other individuals would be abnormally high for carriers of this variant.", 
            "URL": "http://evidence.pgp-hms.org/OPTN-M98K", 
            "Variant Name": "OPTN-M98K", 
            "Variant Page": "http://evidence.pgp-hms.org/OPTN-M98K", 
            "dbSNP IDs": [
                "rs11258194"
            ]
        }, 
        {
            "Allele Frequency": "0.0074", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "16012594", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MSR1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 3, 
            "PMID List": [
                "12244320", 
                "12958598", 
                "21791690"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with increased risk of Barrett's esophagus and/or esophageal cancer. Our very rough estimate is that the increased risk may be around 4x (25% risk of Barrett's esophagus, assuming population average is 5%, and 1.2% lifetime risk of esophageal cancer compared to average .4% risk).", 
            "URL": "http://evidence.pgp-hms.org/MSR1-R293X", 
            "Variant Name": "MSR1-R293X", 
            "Variant Page": "http://evidence.pgp-hms.org/MSR1-R293X", 
            "dbSNP IDs": [
                "rs41341748"
            ]
        }, 
        {
            "Allele Frequency": "0.32", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "110818598", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "COL4A1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 3, 
            "PMID List": [
                "10334796", 
                "18077766", 
                "20031579"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.", 
            "URL": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "Variant Name": "COL4A1-Q1334H", 
            "Variant Page": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "dbSNP IDs": [
                "rs3742207"
            ]
        }, 
        {
            "Allele Frequency": "0.45", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "7870973", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Metabolism", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MTRR", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 7, 
            "PMID List": [
                "10444342", 
                "10930360", 
                "11807890", 
                "12375236", 
                "15060097", 
                "15979034", 
                "17024475"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "3", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as \"MTRR I22M\" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.", 
            "URL": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "Variant Name": "MTRR-I49M", 
            "Variant Page": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "dbSNP IDs": [
                "rs1801394"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "148459988", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Drug response", 
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "8021009", 
                "\n11250978", 
                "11593098", 
                "16046653", 
                "16675453", 
                "17668390"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.", 
            "URL": "http://evidence.pgp-hms.org/rs5186", 
            "Variant Name": "rs5186", 
            "Variant Page": "http://evidence.pgp-hms.org/rs5186", 
            "dbSNP IDs": [
                "rs5186"
            ]
        }, 
        {
            "Allele Frequency": "0.1", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "54531235", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MBL2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "7564730", 
                "10199352", 
                "17872904"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "2", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele B. See R52C (variant D) and G57E (variant C).", 
            "URL": "http://evidence.pgp-hms.org/MBL2-G54D", 
            "Variant Name": "MBL2-G54D", 
            "Variant Page": "http://evidence.pgp-hms.org/MBL2-G54D", 
            "dbSNP IDs": [
                "rs1800450"
            ]
        }, 
        {
            "Allele Frequency": "0.4", 
            "Build 37 Chromosome": "chr4", 
            "Build 37 Position": "6303354", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision", 
                "Immune system", 
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "WFS1", 
            "Impact": "Not Reviewed", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "17603484", 
                "17719176", 
                "23257691"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "4", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).", 
            "URL": "http://evidence.pgp-hms.org/WFS1-R611H", 
            "Variant Name": "WFS1-R611H", 
            "Variant Page": "http://evidence.pgp-hms.org/WFS1-R611H", 
            "dbSNP IDs": [
                "rs734312"
            ]
        }, 
        {
            "Allele Frequency": "0.14", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TGIF1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 1, 
            "PMID List": [
                "10556296"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.", 
            "URL": "http://evidence.pgp-hms.org/TGIF1-P83Shift", 
            "Variant Name": "TGIF1-P83Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/TGIF1-P83Shift", 
            "dbSNP IDs": [
                "rs11571510"
            ]
        }, 
        {
            "Allele Frequency": "0.63", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7579472", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TP53", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "1975675", 
                "9607760", 
                "15355915", 
                "19837266", 
                "20615891", 
                "22184967"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.", 
            "URL": "http://evidence.pgp-hms.org/TP53-P72R", 
            "Variant Name": "TP53-P72R", 
            "Variant Page": "http://evidence.pgp-hms.org/TP53-P72R", 
            "dbSNP IDs": [
                "rs1042522"
            ]
        }, 
        {
            "Allele Frequency": "0.2", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "55722882", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Mental and behavioral"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "DYX1C1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "12954984"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "2", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "One study reports this variant to be associated with dyslexia. The study group was relatively small and so the results did not have strong significance. If they are representative this variant is associated with a doubled risk for dyslexia, but it is unclear whether the effect would be additive, dominant, or recessive.", 
            "URL": "http://evidence.pgp-hms.org/DYX1C1-E417X", 
            "Variant Name": "DYX1C1-E417X", 
            "Variant Page": "http://evidence.pgp-hms.org/DYX1C1-E417X", 
            "dbSNP IDs": [
                "rs57809907"
            ]
        }, 
        {
            "Allele Frequency": "0.24", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "32906729", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "BRCA2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "11062481", 
                "15235023"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.", 
            "URL": "http://evidence.pgp-hms.org/BRCA2-N372H", 
            "Variant Name": "BRCA2-N372H", 
            "Variant Page": "http://evidence.pgp-hms.org/BRCA2-N372H", 
            "dbSNP IDs": [
                "rs144848"
            ]
        }, 
        {
            "Allele Frequency": "0.86", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "231050715", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SP110", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16803959"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.", 
            "URL": "http://evidence.pgp-hms.org/SP110-L425S", 
            "Variant Name": "SP110-L425S", 
            "Variant Page": "http://evidence.pgp-hms.org/SP110-L425S", 
            "dbSNP IDs": [
                "rs3948464"
            ]
        }, 
        {
            "Allele Frequency": "0.31", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "9323910", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Genital and urinary", 
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "H6PD", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "12858176", 
                "15827106", 
                "16817821"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "3", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).", 
            "URL": "http://evidence.pgp-hms.org/H6PD-R453Q", 
            "Variant Name": "H6PD-R453Q", 
            "Variant Page": "http://evidence.pgp-hms.org/H6PD-R453Q", 
            "dbSNP IDs": [
                "rs6688832"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "16251599", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ABCC6", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "10811882", 
                "10913334", 
                "11776382", 
                "20038957"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.", 
            "URL": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
            "Variant Name": "ABCC6-R1268Q", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
            "dbSNP IDs": [
                "rs2238472"
            ]
        }, 
        {
            "Allele Frequency": "0.49", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "49206674", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Blood", 
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "FUT2", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "7876235", 
                "12692541", 
                "19625485", 
                "20031047", 
                "22025362"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "5", 
                "Severity": "2", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are \"non-secretors\": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.", 
            "URL": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "Variant Name": "FUT2-W154X", 
            "Variant Page": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "dbSNP IDs": [
                "rs601338"
            ]
        }, 
        {
            "Allele Frequency": "0.34", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "4680251", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "PRNP", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "18236005", 
                "19081515"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.\n\n", 
            "URL": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "Variant Name": "PRNP-M129V", 
            "Variant Page": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "dbSNP IDs": [
                "rs1799990"
            ]
        }, 
        {
            "Allele Frequency": "0.74", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "17409572", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KCNJ11", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "17463246", 
                "17463248", 
                "20054294"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.", 
            "URL": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "Variant Name": "KCNJ11-K23E", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "dbSNP IDs": [
                "rs5219"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "237048500", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MTR", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "10498402", 
                "14744749", 
                "17417062", 
                "17855192"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.\n\n\n", 
            "URL": "http://evidence.pgp-hms.org/MTR-D919G", 
            "Variant Name": "MTR-D919G", 
            "Variant Page": "http://evidence.pgp-hms.org/MTR-D919G", 
            "dbSNP IDs": [
                "rs1805087"
            ]
        }, 
        {
            "Allele Frequency": "0.18", 
            "Build 37 Chromosome": "chr22", 
            "Build 37 Position": "51064416", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "ARSA", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "2574462"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant (HapMap 24.1% allele frequency) causes a loss of a glycosylation site (affecting the size of the protein when studied with gel electrophoresis) but does not affect enzyme activity or stability.", 
            "URL": "http://evidence.pgp-hms.org/ARSA-N350S", 
            "Variant Name": "ARSA-N350S", 
            "Variant Page": "http://evidence.pgp-hms.org/ARSA-N350S", 
            "dbSNP IDs": [
                "rs2071421"
            ]
        }, 
        {
            "Allele Frequency": "0.03", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "43280227", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "ADA", 
            "Impact": "Benign", 
            "Inheritance": "Dominant", 
            "PMID Count": 7, 
            "PMID List": [
                "7316475", 
                "8031011", 
                "11354825", 
                "16221767", 
                "17340203", 
                "21359089", 
                "21734253"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant is reported to reduce adenosine deaminase enzyme activity. It has been associated with an increased tendency for non-REM sleep -- more slow wave sleep, less nocturnal wakings, and a stronger negative impact of sleep deprivation. A role for this gene and variant was previously proposed for autism susceptibility, but this is controversial and was not replicated by later studies.", 
            "URL": "http://evidence.pgp-hms.org/ADA-D8N", 
            "Variant Name": "ADA-D8N", 
            "Variant Page": "http://evidence.pgp-hms.org/ADA-D8N", 
            "dbSNP IDs": [
                "rs73598374"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "201052310", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CACNA1S", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Common polymorphism", 
            "URL": "http://evidence.pgp-hms.org/CACNA1S-L458H", 
            "Variant Name": "CACNA1S-L458H", 
            "Variant Page": "http://evidence.pgp-hms.org/CACNA1S-L458H", 
            "dbSNP IDs": [
                "rs12742169"
            ]
        }, 
        {
            "Allele Frequency": "0.032", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "142655008", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "KEL", 
            "Impact": "Benign", 
            "Inheritance": "Dominant", 
            "PMID Count": 1, 
            "PMID List": [
                "7849312"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": "5", 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is also known as Kell or K1 or K (capitalized) in the Kell antigen system. K1-negative mothers (carrying no copies of this variant) carrying K1-positive fetuses (heterozygous or homozygous) are at risk for hemolytic disease of the newborn. About 9% of caucasians carry one or two copies of K1.", 
            "URL": "http://evidence.pgp-hms.org/KEL-T193M", 
            "Variant Name": "KEL-T193M", 
            "Variant Page": "http://evidence.pgp-hms.org/KEL-T193M", 
            "dbSNP IDs": [
                "rs8176058"
            ]
        }, 
        {
            "Allele Frequency": "0.24", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "37053568", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MLH1", 
            "Impact": "Benign", 
            "Inheritance": "Dominant", 
            "PMID Count": 8, 
            "PMID List": [
                "11781295", 
                "12810663", 
                "17074586", 
                "17510385", 
                "17870204", 
                "19863800", 
                "20301390", 
                "22631669"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.", 
            "URL": "http://evidence.pgp-hms.org/MLH1-I219V", 
            "Variant Name": "MLH1-I219V", 
            "Variant Page": "http://evidence.pgp-hms.org/MLH1-I219V", 
            "dbSNP IDs": [
                "rs1799977"
            ]
        }, 
        {
            "Allele Frequency": "0.26", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "74219546", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LOXL1", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "17690259", 
                "18450598", 
                "20142848"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.", 
            "URL": "http://evidence.pgp-hms.org/LOXL1-R141L", 
            "Variant Name": "LOXL1-R141L", 
            "Variant Page": "http://evidence.pgp-hms.org/LOXL1-R141L", 
            "dbSNP IDs": [
                "rs1048661"
            ]
        }, 
        {
            "Allele Frequency": "1.0", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "21235475", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "APOB", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "5", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This position is almost certainly an error in the HG18 reference sequence. ", 
            "URL": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "Variant Name": "APOB-Y1422C", 
            "Variant Page": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "dbSNP IDs": [
                "rs568413"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7906519", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "GUCY2D", 
            "Impact": "Benign", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "8944027"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/GUCY2D-A52S", 
            "Variant Name": "GUCY2D-A52S", 
            "Variant Page": "http://evidence.pgp-hms.org/GUCY2D-A52S", 
            "dbSNP IDs": [
                "rs61749665"
            ]
        }, 
        {
            "Allele Frequency": "0.042", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "52760957", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "KRT85", 
            "Impact": "Benign", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "16525032", 
                "19865094"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": "-1", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign. Although this variant was implicated in causing ectodermal dysplasia in a recessive manner in two Pakistani families (one of which was large and consanguineous), GET-Evidence reports that the variant has been seen in 5 out of 114 random control chromosomes. This strongly contradicts a severe pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/KRT85-R78H", 
            "Variant Name": "KRT85-R78H", 
            "Variant Page": "http://evidence.pgp-hms.org/KRT85-R78H", 
            "dbSNP IDs": [
                "rs61630004"
            ]
        }, 
        {
            "Allele Frequency": "0.29", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "68855363", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TPCN2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "18488028"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Pigmentation allele.", 
            "URL": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "Variant Name": "TPCN2-G734E", 
            "Variant Page": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "dbSNP IDs": [
                "rs3829241"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "55539395", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12764676", 
                "19364639"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.", 
            "URL": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "Variant Name": "RP1-N985Y", 
            "Variant Page": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "dbSNP IDs": [
                "rs2293869"
            ]
        }, 
        {
            "Allele Frequency": "0.098", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "48258198", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ABCC11", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "14471313", 
                "16444273"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "5", 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with dry type ear wax (a benign trait) in a recessive manner.", 
            "URL": "http://evidence.pgp-hms.org/ABCC11-G180R", 
            "Variant Name": "ABCC11-G180R", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCC11-G180R", 
            "dbSNP IDs": [
                "rs17822931"
            ]
        }, 
        {
            "Allele Frequency": "0.69", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "33951693", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC45A2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "15714523", 
                "17044855", 
                "18563784", 
                "18806926"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.", 
            "URL": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "Variant Name": "SLC45A2-L374F", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "dbSNP IDs": [
                "rs16891982"
            ]
        }, 
        {
            "Allele Frequency": "0.46", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141672604", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12595690", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with \"taster\" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "Variant Name": "TAS2R38-I296V", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "dbSNP IDs": [
                "rs10246939"
            ]
        }, 
        {
            "Allele Frequency": "0.89", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "55529187", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCSK9", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19351729"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is likely benign. ", 
            "URL": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "Variant Name": "PCSK9-G670E", 
            "Variant Page": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "dbSNP IDs": [
                "rs505151"
            ]
        }, 
        {
            "Allele Frequency": "0.43", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141673345", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "12595690", 
                "15883422", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "5", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is strongly associated with causing the \"taster\" phenotype of phenylthiocarbamine (PTC) in a dominant manner.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "Variant Name": "TAS2R38-A49P", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "dbSNP IDs": [
                "rs713598"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "88911696", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "17952075", 
                "17999355"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).", 
            "URL": "http://evidence.pgp-hms.org/TYR-S192Y", 
            "Variant Name": "TYR-S192Y", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-S192Y", 
            "dbSNP IDs": [
                "rs1042602"
            ]
        }
    ]
}